As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...

NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...

MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated EGFR-mutated NSCLC. RAHWAY, N.J., September 18, 2024--Merck ...

Osaka Metropolitan University researchers analyzed the incidence in Japan of COVID-19-associated pulmonary aspergillosis ...

Today’s positive decision follows the manufacturer, Daiichi Sankyo, offering a fair price for the treatment that the National Institute for Health and Care Excellence (NICE) determined to be ...

Global events can pose significant challenges to the supply of APIs, and thus the continuity of drug supply. Any disruption ...

At a thrombosis research center, an observational study is underway investigating the impact of numerous biomarkers on ...

US CDMO BioCentriq has appointed Syed Husain as its new CEO. Husain, who brings over 20 years of experience in CDMO ...

Diabetic Macular Edema Market valuation is set to cross USD 4,642.9 million by 2034, at a CAGR of 1.2% through 2034.

EY Pune employee's death: Shobha Karandlaje was responding to Rajeev Chandrasekhar's post who called the woman's death very sad and “disturbing at many levels”.

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

Out of 50 states, just seven are likely to decide whether Donald Trump or Kamala Harris will win the 2024 US elections. With election day on the horizon, each candidate is looking to turn as many ...